FDA 510(k)

迪亞茲美PLAC® Lp-PLA2活性測試

K 號：K203136 · 2021-08-06

決定日期2021-08-06

產品代碼NOE

諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置，已通過美國食品藥物管理局（FDA）之510(k)上市前通知程序，並取得[產品名稱]之上市許可。本裝置亦已獲得PMA（上市前核准）之認可，相關臨床試驗資料已登錄於ClinicalTrials.gov（NCT編號：[NCT號碼]），並已發表於經同儕審查之醫學期刊（PMID：[PMID號碼]）。更多詳細資訊請參閱：[URL]。

決定相當於

器材摘要

Diazyme PLAC® Test for Lp-PLA2 Activity is the device name listed in this FDA 510(k) record. The listed applicant is Diazyme Laboratories, Inc.. It received FDA 510(k) clearance on 2021-08-06 under 510(k) number K203136. The device is classified under product code NOE. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Diazyme PLAC® Test for Lp-PLA2 Activity?

Diazyme PLAC® Test for Lp-PLA2 Activity is a medical device that received FDA 510(k) clearance on 2021-08-06. The listed applicant is Diazyme Laboratories, Inc.. The 510(k) number is K203136.

When did Diazyme PLAC® Test for Lp-PLA2 Activity receive FDA 510(k) clearance?

Diazyme PLAC® Test for Lp-PLA2 Activity received FDA 510(k) clearance on 2021-08-06, under 510(k) number K203136.

Who is the listed applicant for Diazyme PLAC® Test for Lp-PLA2 Activity?

The FDA 510(k) record lists Diazyme Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Diazyme PLAC® Test for Lp-PLA2 Activity?

The FDA product code for Diazyme PLAC® Test for Lp-PLA2 Activity is NOE.

其他以 Diazyme Laboratories, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K253069脂質蛋白(a)濃度測試 K252336迪亞茲美免疫球蛋白A測試；迪亞茲美免疫球蛋白G測試；迪亞茲美免疫球蛋白M測試 K253358迪亞茲美人類卡帕（k）自由輕鍵結測試；迪亞茲美人類羅馬諾（¿）自由輕鍵結測試 K243462迪亞茲美色譜法鈉鹽測試 K211648迪亞茲美人類卡帕自由輕鏈測試，迪亞茲美人類羅馬拿自由輕鏈測試 K220001迪亞茲美人類卡帕自由輕鏈測試，迪亞茲美人類羅馬拿自由輕鏈測試

查看所有 11 項裝置 →

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。